SUPN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Supernus Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 43.97 USD -1.41%

Market Cap: $2.6B

	Supernus Pharmaceuticals Inc NASDAQ:SUPN	US
A	Aflac Inc LSE:0H68	US
	Unggul Indah Cahaya Tbk PT IDX:UNIC	ID
	ASML Holding NV SIX:ASML	NL
V	Verisk Analytics Inc XMUN:VA7A	US
	Darma Henwa Tbk PT IDX:DEWA	ID
	Rocket Lab USA Inc F:6RJ	US
	Exelon Corp NASDAQ:EXC	US
	Celestica Inc F:CTW0	CA
	Agricultural Bank of China Ltd F:EK7	CN
C	Canadian Tire Corporation Ltd F:YAAA	CA

Profitability Summary

Supernus Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

88%

Strong 3Y Average Gross Margin

89%

Gross Margin is Increasing

86% > 88%

Negative Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

5% > 0%

Negative Net Margin

-13%

Low 3Y Average Net Margin

Declining Net Margin

4% > -13%

Healthy Free Cash Flow Margin

Strong 3Y Average Free Cash Flow Margin

17%

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.